Dr. Greenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1025
Education & Training
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1971 - 1975
State University of New York Downstate Medical Center College of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1973 - Present
WA State Medical License 1976 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 570 citationsMultiple early factors anticipate post-acute COVID-19 sequelae.Yapeng Su, Dan Yuan, Daniel G Chen, Rachel H Ng, Kai Wang
Cell. 2022-03-03 - 1453 citationsReconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donorElizabeth A. Walter, Phil Greenberg, Mark J. Gilbert, R. J. Finch, Kathe S. Watanabe
The New England Journal of Medicine. 1995-10-19 - 147 citationsAccumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.Teresa Manzo, Boone M. Prentice, Kristin G. Anderson, Ayush T. Raman, Aislyn Schalck
The Journal of Experimental Medicine. 2020-08-03
Press Mentions
Experts Forecast Cancer Research and Treatment Advances in 2023January 13th, 2023- Colon Cancer Patient Who Turned Away from NHS ‘Disease-Free’ for 6 Years After Being Told He Had Months to LiveSeptember 11th, 2022
- Damon Runyon Cancer Research Foundation Awards Quantitative Biology Fellowships to Three Cutting-Edge ScientistsApril 18th, 2022
- Join now to see all
Grant Support
- Specific Adoptive Immunotherapy Of LeukemiaNational Cancer Institute2007–2011
- Mechanisms Of Murine Tumor Eradication By ImmunotherapyNational Cancer Institute1986–2011
- Safety And Antiviral Efficacy Of Immunotherapy With Autologous CD8+ Hiv-SpecificNational Center For Research Resources2007
- Biologic Activity Of Transferred Hiv-Specific CD8 ClonesNational Institute Of Allergy And Infectious Diseases2003–2007
- Adoptive Transfer Of Shiv-Specific CD8+ T CellsNational Center For Research Resources2006
- Mechanisms Of Murine Tumor Eradication By ImmunotherapyNational Cancer Institute1991–2006
- Adoptive Transfer Of Autologous Shiv-Specific Cd+-T CellsNational Center For Research Resources2004–2005
- Enhancement Of Immune Responsiveness To Vacc. By Treatment With Anti-Ctla-4National Center For Research Resources2003
- Adoptive Transfer Of Autologous Shiv-Specific Cd*+-T CellsNational Center For Research Resources2003
- Specific Adoptive Immunotherapy Of Malignant DiseasesNational Cancer Institute2002
- Core--Molecular ImmunologyNational Institute Of Allergy And Infectious Diseases1998–2002
- Cellular Immune Responses To Subunit Immunodeficiency Virus VaccinesNational Institute Of Allergy And Infectious Diseases1998–2002
- Adoptive Transfer Of SIV Specific CD8+ T Cell Clones In MacaquesNational Center For Research Resources1999–2001
- Transfer Of Hiv-Specific CD4+ T Cell Clones With Genes Inhibiting HIVNational Institute Of Allergy And Infectious Diseases1998–2001
- Therapy Of HIV With Genetically Modified T Cell ClonesNational Institute Of Allergy And Infectious Diseases1998–2001
- Specific Adoptive Immunotherapy Of Viral DiseasesNational Cancer Institute1997–2001
- Transfer Of CD4 T Cell Clones With Genes Inhibiting HIVNational Center For Research Resources1998–1999
- Transfer Of CD4+ T Cell Clones With Genes Inhibiting HIVNational Institute Of Allergy And Infectious Diseases1996–1997
- Core--ImmunologyNational Institute Of Allergy And Infectious Diseases1996–1997
- Cellular Immune Responses To Subunit Immunodeficiency Virus VaccinesNational Institute Of Allergy And Infectious Diseases1996–1997
- Therapy Of HIV With Genetically Modified T Cell ClonesNational Institute Of Allergy And Infectious Diseases1994–1997
- Specific Adoptive Immunotherapy Of Human Disease With T-Cell ClonesNational Cancer Institute1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
